A detailed history of Prestige Wealth Management Group LLC transactions in Incyte Corp stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 234 shares of INCY stock, worth $13,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
234
Previous 143 63.64%
Holding current value
$13,415
Previous $8,000 62.5%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$56.55 - $66.59 $5,146 - $6,059
91 Added 63.64%
234 $13,000
Q4 2023

Apr 26, 2024

SELL
$52.16 - $64.19 $7,928 - $9,756
-152 Reduced 51.53%
143 $8,000
Q4 2023

Feb 08, 2024

SELL
$52.16 - $64.19 $7,928 - $9,756
-152 Reduced 51.53%
143 $8,000
Q3 2023

Apr 26, 2024

BUY
$57.77 - $65.93 $1,270 - $1,450
22 Added 8.06%
295 $17,000
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $1,270 - $1,450
22 Added 8.06%
295 $17,000
Q2 2023

Apr 26, 2024

SELL
$60.95 - $75.51 $2,255 - $2,793
-37 Reduced 11.94%
273 $16,000
Q2 2023

Aug 11, 2023

SELL
$60.95 - $75.51 $2,255 - $2,793
-37 Reduced 11.94%
273 $16,000
Q1 2023

Apr 26, 2024

BUY
$70.23 - $86.01 $5,337 - $6,536
76 Added 32.48%
310 $22,000
Q1 2023

May 16, 2023

BUY
$70.23 - $86.01 $280 - $344
4 Added 1.31%
310 $22,000
Q4 2022

Feb 07, 2023

BUY
$67.18 - $84.11 $3,896 - $4,878
58 Added 23.39%
306 $24,000
Q3 2022

Nov 01, 2022

SELL
$66.18 - $82.86 $2,316 - $2,900
-35 Reduced 12.37%
248 $16,000
Q2 2022

Aug 10, 2022

BUY
$66.18 - $83.18 $132 - $166
2 Added 0.71%
283 $21,000
Q1 2022

May 05, 2022

SELL
$66.02 - $79.71 $594 - $717
-9 Reduced 3.1%
281 $23,000
Q4 2021

Feb 15, 2022

BUY
$63.34 - $74.11 $11,464 - $13,413
181 Added 166.06%
290 $22,000
Q3 2021

Nov 12, 2021

SELL
$68.67 - $84.02 $5,768 - $7,057
-84 Reduced 43.52%
109 $8,000
Q2 2021

Aug 12, 2021

BUY
$79.87 - $87.53 $3,354 - $3,676
42 Added 27.81%
193 $16,000
Q1 2021

May 13, 2021

SELL
$76.02 - $100.5 $6,993 - $9,246
-92 Reduced 37.86%
151 $13,000
Q4 2020

Feb 17, 2021

BUY
$80.74 - $97.7 $1,534 - $1,856
19 Added 8.48%
243 $22,000
Q3 2020

Oct 26, 2020

BUY
$85.07 - $109.69 $2,977 - $3,839
35 Added 18.52%
224 $20,000
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $2,967 - $4,357
40 Added 26.85%
189 $20,000
Q1 2020

May 15, 2020

BUY
$63.18 - $85.97 $4,612 - $6,275
73 Added 96.05%
149 $11,000
Q1 2019

Aug 16, 2019

SELL
$63.56 - $88.17 $10,932 - $15,165
-172 Reduced 69.35%
76 $7,000
Q4 2018

Apr 16, 2019

BUY
$58.5 - $69.94 $14,508 - $17,345
248 New
248 $16,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $12.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.